À medida que os fabricantes de produtos farmacêuticos buscam novas soluções para condições desafiadoras, os canabinoides - especialmente o canabidiol (CBD) - estão surgindo como candidatos promissores para a inovação de medicamentos. Com desenvolvimentos regulatórios favoráveis e evidências científicas cada vez maiores que apoiam seu potencial no tratamento de distúrbios do sistema nervoso central, dor e câncer, os canabinoides estão prontos para expandir as possibilidades terapêuticas. Este whitepaper explora as pesquisas mais recentes sobre canabinoides e destaca como a dsm-firmenich está fazendo parcerias com o setor farmacêutico para impulsionar o desenvolvimento de medicamentos em estágio inicial nesse campo empolgante.
Discover how dsm-firmenich and Bayer reduced vitamin C’s carbon footprint by 49% through renewable energy, process innovation, and sustainable pharma collaboration.
Discover how dsm-firmenich is tackling the challenge of bitter medicine with a receptor-based technology designed to elevate drug palatability and improve patient adherence.
Explore how dsm-firmenich can help pharma raise the bar in patient-centricity and sustainability.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.